l , Schematic highlighting the nucleus accumbens
Wegovy (semaglutide) imitates the hormone GLP-1 which controls appetite, but does not completely eliminate hunger
Together, the effects of stimulating insulin, reducing glucagon, and delaying gastric emptying improve glycemic control, resulting in a favorable hypoglycemia profile
Pharmacoepidemiol Drug Saf (2004) 13(6):38794
Individual response varies based on genetics, drinking history, the specific medication and dose, and co-occurring conditions
The therapies available through the Medical Weight Loss and GLP-1 Treatment Program at Taylor Bariatric Institute reflect a broad spectrum of evidence-based options that address hunger intensity, portion control, cravings, emotional eating, metabolic instability, and reward-driven food impulses